INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $994 | +235.8% | 31,436 | +333.1% | 0.01% | +350.0% |
Q2 2023 | $296 | -14.9% | 7,258 | -27.3% | 0.00% | -60.0% |
Q4 2022 | $348 | -100.0% | 9,982 | -41.9% | 0.01% | -61.5% |
Q3 2022 | $962,000 | +135.2% | 17,186 | +117.5% | 0.01% | +160.0% |
Q2 2022 | $409,000 | -67.4% | 7,903 | -54.2% | 0.01% | -68.8% |
Q1 2022 | $1,253,000 | +169.5% | 17,243 | +397.3% | 0.02% | +166.7% |
Q3 2021 | $465,000 | -6.4% | 3,467 | -62.0% | 0.01% | +20.0% |
Q4 2020 | $497,000 | -54.3% | 9,134 | -83.3% | 0.01% | -77.3% |
Q3 2020 | $1,088,000 | +33.2% | 54,723 | +40.7% | 0.02% | +4.8% |
Q2 2020 | $817,000 | +366.9% | 38,882 | +197.1% | 0.02% | +250.0% |
Q3 2019 | $175,000 | – | 13,089 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |